Show simple item record

dc.contributor.authorAdetayo, O
dc.contributor.authorOmoni, GM
dc.contributor.authorAluko, Rotimi
dc.date.accessioned2013-06-29T07:55:52Z
dc.date.available2013-06-29T07:55:52Z
dc.date.issued2005
dc.identifier.citationVolume 16, Issue 8, August 2005, Pages 344–350en
dc.identifier.urihttp://www.sciencedirect.com/science/article/pii/S0924224405000373
dc.identifier.urihttp://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/42131
dc.description.abstractConsiderable evidence from several epidemiological studies suggests that lycopene has anti-carcinogenic and anti-atherogenic potential, the effects of which have been attributed primarily to its antioxidant properties (lycopene quenches singlet oxygen almost twice as well as β-carotene does). These epidemiological leads have stimulated a number of animal model and cell culture studies designed to test this hypothesis and to establish its beneficial effects. This review will focus on the anti-atherogenic and anti-carcinogenic effects of lycopene, and point out areas for future research to further elucidate mechanisms whereby this compound may reduce cancer and cardiovascular disease risk.en
dc.language.isoenen
dc.relation.ispartofseriesVolume16;
dc.titleThe anti-carcinogenic and anti-atherogenic effects of lycopene: a reviewen
dc.typeArticleen
local.publisherSchool of Nursingen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record